Abstract
Dose-dependent effect of synthetic heptapeptides Semax (Met-Glu-His-Phe-Pro-Gly-Pro) and Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) on the enkephalin-degrading enzymes of human serum was demonstrated. The inhibitory effects of Semax (IC5010 μM) and Selank (IC5020 μM) are more pronounced than that of puromycin (IC5010 mM), bacitracin, and some other inhibitors of peptidases. Beside the heptapeptides, their pentapeptide fragments also possessed an inhibitory effect; tri-, tetra- and hexapeptide fragments did not display such an effect. As the above enzymes take part in degradation of not only enkephalins but also other regulatory peptides, it can be assumed that one of the mechanisms of biological activity of Semax and Selank is related to this inhibitory activity of theirs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Ponomareva-Stepnaya, M.A., Nezavibat'ko, V.N., Antonova, L.V., Andreeva, L.A., Alfeeva, L.Yu., Potaman, V.N., Kamenskii, A.A., and Ashmarin, I.P., Khim.–Farm.Zh. 1984, vol. 18, pp. 790-795.
Semenova, T.P., Kozlovskaya, M.M., Val'dman, A.V., and Gromova, E.A., Byull.Eksp.Biol.Med., 1988, vol. 106, pp. 161-163.
Seredinin, S.B., Kozlovskaya, M.M., Blednov, Yu.A., Kozlovskii, I.I., Semenova, T.P., Chabak-Gorbach, R., Nezavibat'ko, V.N., and Myasoedov, N.F.,Zh.Vyssh.Nervn.Deyat., 1998, vol. 48, pp. 153-160.
Ashmarin, I.P., Nezavibatko, V.N., Levtskaya, N.G., Koshelev, V.N., and Kamensky, A.A., Neurosci.Res.Communs, 1995, vol. 16, pp. 105-112.
Ashmarin, I.P., Nezavibat'ko, V.N., Myasoedov, N.F., Kamenskii, A.A., Grivennikov, I.A., Ponomareva-Stepnaya, M.A., Andreeva, L.A., Kaplan, A.Ya., Koshelev, V.B., and Ryasina, T.V.,Zh.Vyssh.Nervn.Deyat.1997, vol. 47, pp. 420-430.
Gusev, E.I., Skvortsova, V.I., Myasoedov, N.F., Nezavibat'ko, V.N., Zhuravleva, E.Yu., and Vanichkin, A.V., Zh.Nevropat.Psikh.im.A.A.Korsakova, 1997, vol. pp. 26-34.
Grivennikov, I.A., Dolotov, O.V., and Gol'dina, Yu.I., Mol.Biol.(Moscow), 1999, vol. 33, pp. 27-31.
Il'inskii, O.B., Neirofiziologiya (Kiev), 1985, vol. 17, pp. 550-556.
Zagon, I.S., Goodman, S.R., and McLaughlin, P.J., Brain Res., 1989, vol. 482, pp. 297-305.
Shen, Y. and Li, R., Med.Hypotheses, 1995, vol. 45, pp. 529-538.
Zozulya, A.A., Meshavkin, V.K., Toropov, A.V., Gurevich, K.G., and Kost, N.V., Byull.Eksp.Biol.Med., 1999, vol. 127, pp. 211-214.
Ashmarin, I.P., Stukalov, P.V., and Eshchenko, N.D., Biokhimiya mozga (Brain Biochemistry), St. Petersburg: Izd. St. Petersb. Univ., 1999.
Marini, M., Roscetti, G., Bonjiorno, L., Urbani, A., and Rodo, L., Neurochem.Res, 1990, vol. 15, pp. 61-67.
Sokolov, O.Yu., Gabaeva, M.V., Gurevich, K.G., Akatova, E.V., Alfimova, M.V., and Kost, N.V.,Neirokhimiya, 2000, vol. 17, pp. 150-156.
Potaman, V.N., Alfeeva, L.Y., Kamensky, A.A., and Nezavibatko, V.N., Peptides, London: Pergamon, 1993, vol. 14, p. 491.
Inozemtsev, A.N., Kokaeva, F.F., Kozlovskii, I.I., and Sarycheva, E.I., Byull.Eksp.Biol.Med, 1990, vol. 109, pp. 445-446.
Zoloev, G.K., Kovalenko, N.Ya., and Matsievskii, D.D., Patol.Fiziol.Eksp.Terapiya, 1988, vol. 3, pp. 48-51.
Lishmanov, Yu.V. and Maslov, L.N., Opioidnye neiropeptidy, stress i adaptatsionnaya zashchita serdtsa (Opioid Neuropeptides, Stress and Adaptation Protection of Heart), Tomsk: Izd. Tomsk. Univ., 1994, p. 352.
Zolotarev, Yu.A., Dorokhova, E.M., Nezavibatko, V.N., Borisov, Yu.A., Rosenberg, S.G., and Myasoedov, N.F., Amino Acids, 1995, vol. 47, pp. 353-365.
Ponomareva-Stepnaya, M.A., Nezavibat'ko, V.N., Potaman, V.N., Kozlovskaya, M.M., Val'dman, A.V., and Bondarenko, N.A., Pat. RF 1124544, Bull.Izobret., 1995, no. 1, p. 260.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kost, N.V., Sokolov, O.Y., Gabaeva, M.V. et al. Semax and Selank Inhibit the Enkephalin-Degrading Enzymes of Human Serum. Russian Journal of Bioorganic Chemistry 27, 156–159 (2001). https://doi.org/10.1023/A:1011373002885
Issue Date:
DOI: https://doi.org/10.1023/A:1011373002885